Table 5 Case study
From: CollaboNet: collaboration of deep neural networks for biomedical named entity recognition
| Â | Chemical dataset | Â |
Our STM | No prophylaxis with antilymphocyte globulin was used | - globulin : Protein |
CollaboNet | No prophylaxis with antilymphocyte globulin was used | Â |
Ground Truth | No prophylaxis with antilymphocyte globulin was used | Â |
Our STM | elderly patients using ACE / ARB in combination with potassium | ACE : Gene/Protein |
CollaboNet | elderly patients using ACE / ARB in combination with potassium | Â |
Ground Truth | elderly patients using ACE / ARB in combination with potassium | Â |
| Â | Disease Dataset | Â |
Our STM | The ATM (A-T, mutated) gene on human chromosome 11q22. | A-T, mutated : Gene |
CollaboNet | The ATM (A-T, mutated) gene on human chromosome 11q22. | Â |
Ground Truth | The ATM (A-T, mutated) gene on human chromosome 11q22. | Â |
Our STM | to bind to the human cardiac troponin T (cTNT) pre-messenger RNA | cTNT : Gene/Protein |
CollaboNet | to bind to the human cardiac troponin T (cTNT) pre-messenger RNA | Â |
Ground Truth | to bind to the human cardiac troponin T (cTNT) pre-messenger RNA | Â |
| Â | Gene / Protein Dataset | Â |
Our STM | which is inhibited by the cytotoxin leptomycin B (LMB), and also by its interaction | LMB : Chemical, Drug |
CollaboNet | which is inhibited by the cytotoxin leptomycin B (LMB), and also by its interaction | Â |
Ground Truth | which is inhibited by the cytotoxin leptomycin B (LMB), and also by its interaction | Â |
Our STM | Classic Hodgkin disease (cHD) is derived from B cells with high loads of mutations. | cHD : Disease |
CollaboNet | Classic Hodgkin disease (cHD) is derived from B cells with high loads of mutations | Â |
Ground Truth | Classic Hodgkin disease (cHD) is derived from B cells with high loads of mutations | Â |